Deciding when to intervene: A Markov decision process approach

International Journal of Medical Informatics

Volumn 60, Issue 3, 2000, Pages 237-253

  Magni, Paolo ^a   Quaglini, Silvana ^a   Marchetti, Monia ^b   Barosi, Giovanni ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Decision models; Decision theory; Decisions and time; Hereditary spherocytosis; Markov decision processes; Therapy planning

Indexed keywords

DECISION MAKING; DISEASES; MEDICAL PROBLEMS; PATIENT TREATMENT; STRATEGIC PLANNING;

HEREDITARY SPHEROCYTOSIS; MARKOV DECISION PROCESSES; THERAPY PLANNING;

DECISION THEORY;

ALGORITHM; DYNAMICS; HEREDITARY SPHEROCYTOSIS; INFORMATION SCIENCE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MODEL; PRIORITY JOURNAL; PROBABILITY; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 0034530018     PISSN: 13865056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-5056(00)00099-X     Document Type: Article

References (24)

1. Representation and analysis of medical decision problems with influence diagrams
2. Decision analysis-effects of prophylactic mastectomy and ooforectomy on life expectancy among women with BRCA1 or BRCA2 mutations
3. Dynamic programming and influence diagrams
4. An integrated approach to Dynamic Decision Making under Uncertainty
5. DT-Planner: An environment for managing dynamic decision problems
6. Dynamic decision analysis in medicine: A data-driven approach
7. Variable clinical severity of hereditary spherocytosis: Relation to erythrocytic spectrin concentration, osmotic fragility and autohemolysis
8. Erythropoietin production and erythropoiesis in compensated and anaernic states of hereditary spherocytosis
9. Surgical indications in cholelithiasis: Prophylactic cholecystectomy elucidated on the basis of long-term follow-up on 526 non-operated cases
10. The hazard of infection following splenectomy in children
11. Postsplenectomy sepsis and its mortality rate: Actual versus perceived risks
12. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: Analyzing the decision in different clinical scenarios
13. Hereditary spherocytosis: Recent experience and current concepts of pathophysiology
14. A markov decision process: Screening hereditary hemochromatosis
15. Using uncertainty management techniques in medical therapy planning: A decision-theoretic approach. Applications of Uncertainty Formalisms
16. Cost-effectiveness analysis for evaluation of screening programs: Hereditary hemochromatosis
17. Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping